⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for programmed cell death 1 ligand 1

Every month we try and update this database with for programmed cell death 1 ligand 1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the SkinNCT02883556
Carcinoma, Squa...
Pembrolizumab
18 Years - Assistance Publique - Hôpitaux de Paris
Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)NCT06228066
Small Cell Carc...
High Grade Neur...
Lurbinectedin
Avelumab
18 Years - 120 YearsNational Institutes of Health Clinical Center (CC)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: